BFEC
TXG icon

Benjamin F. Edwards & Company’s 10x Genomics TXG Stock Holding History

Benjamin F. Edwards & Company’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$871K Buy
44,785
+44,347
+10,125% +$1.16M 0.02% 563
2024
Q1 		$16K Buy
438
+419
+2,205% +$18.4K ﹤0.01% 1593
2023
Q4 		$1K Buy
+19
New +$827 ﹤0.01% 2066

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Benjamin F. Edwards & Company's TXG Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its 10x Genomics (TXG) stake by 10,125% in Q2 2024, buying an estimated $1.16M and bringing the position to 44,785 shares worth $871K. The position accounts for 0.02% of the portfolio, ranked #563.

Benjamin F. Edwards & Company first reported a position in TXG in Q4 2023 and has held it in 3 quarters since. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • Benjamin F. Edwards & Company held 44,785 shares of 10x Genomics worth $871K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 44,347 10x Genomics shares in Q2 2024, an estimated $1.16M.
  • 10x Genomics made up 0.02% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #563 holding.
  • Benjamin F. Edwards & Company first reported a position in 10x Genomics in Q4 2023 and has held it in 3 quarters since.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.